Webb29 jan. 2024 · Gli inibitori di PCSK9 sono anticorpi monoclonali umani, drammaticamente efficaci:riducono infatti i livelli di LDL-C di almeno il 50 - 70%,indipendentemente dalla … WebbLambert, G., Sjouke, B., Choque, B., Kastelein, J.J. and Hovingh, G.K. (2012) The PCSK9 Decade. Thematic Review Series New Lipid and Lipoprotein Targets for the Treatment of …
Modulation of metabolic functions through Cas13d-mediated …
Webb1 apr. 2024 · PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages Article Full-text... Webb7 apr. 2024 · Recent studies have shown that many receptors related to lipid metabolism in macrophages, VSMCs and ECs are mechanosensors, such as TRPV1, TRPV4 and TRPA1 in macrophages, PCSK9 in VSMCs, and SR-B1, LOX-1 and CD36 in ECs. These elements may influence the lipid metabolism in response to altered mechanical forces. Origin of foam … dating an of model
PCSK9, a Review of the Progress from Discovery to Therapy
WebbThe PCSK9 gene provides instructions for making a protein that helps regulate the amount of cholesterol in the bloodstream. Cholesterol is a waxy, fat-like substance that is … Webbwherein the double-stranded RNAi agent comprises a sense strand and an antisense strand forming a double stranded region, the antisense strand comprising a region of complementari Webb12 apr. 2024 · Dyslipidemia treatment is of major importance in reducing the risk of atherosclerotic cardiovascular disease (ASCVD), which is still the most common cause of death worldwide. During the last decade, a novel lipid-lowering drug category has emerged, i.e., proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. Apart from the two … björn walther multiple regression r